XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows    
Cash and cash equivalents $ 11,284 [1] $ 20,335
Restricted cash 27,891 [1] 27,954
Total cash and cash equivalents and restricted cash 39,175 48,289
Supplemental disclosure of non-cash investing and financing activity:    
Debt obligations assumed (refer to Note 3)   99,995
Issuance of common stock for acquisition of assets (refer to Note 3)   35,588
Dividends declared to common shareholders 12,672 2
Accruals for payments of withholding taxes upon vesting for stock-based compensation 1,465  
Accrued finance costs $ 326  
Accrued offering costs   $ 1,443
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).